These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Agranulocytosis due to new sustained-release procainamide. Berger BE; Hauser DJ Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823 [No Abstract] [Full Text] [Related]
25. Reversible procainamide-induced agranulocytosis twice in one patient. Konttinen YP; Tuominen L Lancet; 1971 Oct; 2(7730):925. PubMed ID: 4106683 [No Abstract] [Full Text] [Related]
26. Procainamide-induced agranulocytosis: report of two cases and review. Nagesh KG; Poulose KP; Tseng TH; Schadchehr A J Kans Med Soc; 1980 Jan; 81(1):18-24. PubMed ID: 6153211 [No Abstract] [Full Text] [Related]
27. Septic complications of procainamide-induced agranulocytosis: report of two cases. Freed JS; Reiner MA Mt Sinai J Med; 1988 Mar; 55(2):194-7. PubMed ID: 3290673 [No Abstract] [Full Text] [Related]
28. Reversible severe anaemia and granulocytopenia caused by procainamide. A case report. van Beek RJ; Bieger R; den Ottolander GJ Scand J Haematol; 1978 Aug; 21(2):150-2. PubMed ID: 694426 [TBL] [Abstract][Full Text] [Related]
29. Agranulocytosis during combined procainamide and phenytoin therapy. Crook JE; Woosley RL; Leftwich RB; Natelson EA South Med J; 1979 Dec; 72(12):1599-601. PubMed ID: 515773 [TBL] [Abstract][Full Text] [Related]
30. Agranulocytosis caused by procainamide. Hickson B; Davidson RJ; Walker W Scott Med J; 1972 May; 17(5):165-8. PubMed ID: 4537437 [No Abstract] [Full Text] [Related]
31. Procainamide reactions. Chelius CJ; Nunag AN Wis Med J; 1975 Jan; 74(1):S1-6. PubMed ID: 1114849 [No Abstract] [Full Text] [Related]
33. Desensitization to procainamide. Ream CR; Barrera R J Med Soc N J; 1970 Mar; 67(3):107-10. PubMed ID: 5264623 [No Abstract] [Full Text] [Related]
34. Necrotizing epiglottitis in a patient with procainamide-induced neutropenia. Goldsmith AJ; Schaeffer BT Am J Otolaryngol; 1994; 15(1):58-62. PubMed ID: 7510934 [No Abstract] [Full Text] [Related]
35. Agranulocytosis and lupus erythematosus phenomenon after procaine amide. Oster ZH Isr J Med Sci; 1966; 2(3):354-5. PubMed ID: 5956231 [No Abstract] [Full Text] [Related]
36. Severe transient pancytopenia associated with procainamide ingestion. Bluming AZ; Plotkin D; Rosen P; Thiessen AR JAMA; 1976 Nov; 236(22):2520-1. PubMed ID: 1036516 [TBL] [Abstract][Full Text] [Related]
37. Clozapine-Associated Neutropenia and Agranulocytosis. Andres E; Mourot-Cottet R J Clin Psychopharmacol; 2017 Dec; 37(6):749-750. PubMed ID: 29040154 [No Abstract] [Full Text] [Related]
38. Clozapine, agranulocytosis, and benign ethnic neutropenia. Rajagopal S Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678 [No Abstract] [Full Text] [Related]
39. Administration of filgrastim in two patients with drug-induced agranulocytosis. Castanheira D; Marzella M; Skirvin JA Pharmacotherapy; 1998; 18(6):1347-51. PubMed ID: 9855337 [TBL] [Abstract][Full Text] [Related]
40. [Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents]. Knipping W Med Klin; 1980 Feb; 75(3):108-15. PubMed ID: 7374607 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]